Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats

Wentao Liu, Toru Yamashita, Tomoko Kurata, Syoichiro Kono, Nozomi Hishikawa, Kentaro Deguchi, Yun Zhai, Koji Abe

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives: Hypertension is a crucial risk factor for both stroke and dementia, including Alzheimer’s disease (AD). We inspected the effect of telmisartan on the neurovascular unit (NVU) and related inflammatory responses in spontaneously hypertensive rat stroke resistant (SHR-SR) by observing the components of NVU such as N-acetyl glucosamine oligomer (NAGO), collagen IV, astrocytes, and matrix metalloproteinase-9 (MMP-9), as well as inflammasome NOD-like receptors family protein 3 (NLRP3). Methods: In the present study, we examined the effect of a highly selective angiotensin type 1 (AT-1) antagonist of angiotensin 2 receptor with high lipid solubility, telmisartan, on NVU and related inflammatory responses in SHR-SR with a low dose (0.3 mg/kg/day) only for improving metabolic syndrome, and a high dose (3 mg/kg/day) for improving both metabolic syndrome and SHR-SR hypertension. Results: Compared to normotensive Wistar rats, long-lasting hypertension in SHR-SR disrupted NVU by changing immunohistological components such as NAGO, collagen IV, astrocytes, and MMP-9. SHR-SR also strongly induced AD-related inflammasome NLRP3 in neuronal cells with age. However, such NVU disruption and inflammasome activation were greatly improved with dose-dependent telmisartan treatments. Discussion: These results suggest that telmisartan comprehensively protected the NVU components by reducing inflammatory reactions relative to AD in hypertensive rats, which could also preclude the risk of AD under hypertension.

Original languageEnglish
Pages (from-to)491-501
Number of pages11
JournalNeurological Research
Volume37
Issue number6
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Inflammasomes
Inbred SHR Rats
Stroke
Alzheimer Disease
Hypertension
Glucosamine
Matrix Metalloproteinase 9
Astrocytes
Collagen
Angiotensin II Type 1 Receptor Blockers
Angiotensins
Solubility
Dementia
telmisartan
Wistar Rats
Proteins
Lipids

Keywords

  • AD
  • Hypertension
  • Inflammasome
  • Neurovascular unit
  • SHR-SR
  • Telmisartan

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats. / Liu, Wentao; Yamashita, Toru; Kurata, Tomoko; Kono, Syoichiro; Hishikawa, Nozomi; Deguchi, Kentaro; Zhai, Yun; Abe, Koji.

In: Neurological Research, Vol. 37, No. 6, 01.05.2015, p. 491-501.

Research output: Contribution to journalArticle

@article{bf29f62a14164e9e9650a4ab2fde46b2,
title = "Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats",
abstract = "Objectives: Hypertension is a crucial risk factor for both stroke and dementia, including Alzheimer’s disease (AD). We inspected the effect of telmisartan on the neurovascular unit (NVU) and related inflammatory responses in spontaneously hypertensive rat stroke resistant (SHR-SR) by observing the components of NVU such as N-acetyl glucosamine oligomer (NAGO), collagen IV, astrocytes, and matrix metalloproteinase-9 (MMP-9), as well as inflammasome NOD-like receptors family protein 3 (NLRP3). Methods: In the present study, we examined the effect of a highly selective angiotensin type 1 (AT-1) antagonist of angiotensin 2 receptor with high lipid solubility, telmisartan, on NVU and related inflammatory responses in SHR-SR with a low dose (0.3 mg/kg/day) only for improving metabolic syndrome, and a high dose (3 mg/kg/day) for improving both metabolic syndrome and SHR-SR hypertension. Results: Compared to normotensive Wistar rats, long-lasting hypertension in SHR-SR disrupted NVU by changing immunohistological components such as NAGO, collagen IV, astrocytes, and MMP-9. SHR-SR also strongly induced AD-related inflammasome NLRP3 in neuronal cells with age. However, such NVU disruption and inflammasome activation were greatly improved with dose-dependent telmisartan treatments. Discussion: These results suggest that telmisartan comprehensively protected the NVU components by reducing inflammatory reactions relative to AD in hypertensive rats, which could also preclude the risk of AD under hypertension.",
keywords = "AD, Hypertension, Inflammasome, Neurovascular unit, SHR-SR, Telmisartan",
author = "Wentao Liu and Toru Yamashita and Tomoko Kurata and Syoichiro Kono and Nozomi Hishikawa and Kentaro Deguchi and Yun Zhai and Koji Abe",
year = "2015",
month = "5",
day = "1",
doi = "10.1179/1743132815Y.0000000002",
language = "English",
volume = "37",
pages = "491--501",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "6",

}

TY - JOUR

T1 - Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats

AU - Liu, Wentao

AU - Yamashita, Toru

AU - Kurata, Tomoko

AU - Kono, Syoichiro

AU - Hishikawa, Nozomi

AU - Deguchi, Kentaro

AU - Zhai, Yun

AU - Abe, Koji

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objectives: Hypertension is a crucial risk factor for both stroke and dementia, including Alzheimer’s disease (AD). We inspected the effect of telmisartan on the neurovascular unit (NVU) and related inflammatory responses in spontaneously hypertensive rat stroke resistant (SHR-SR) by observing the components of NVU such as N-acetyl glucosamine oligomer (NAGO), collagen IV, astrocytes, and matrix metalloproteinase-9 (MMP-9), as well as inflammasome NOD-like receptors family protein 3 (NLRP3). Methods: In the present study, we examined the effect of a highly selective angiotensin type 1 (AT-1) antagonist of angiotensin 2 receptor with high lipid solubility, telmisartan, on NVU and related inflammatory responses in SHR-SR with a low dose (0.3 mg/kg/day) only for improving metabolic syndrome, and a high dose (3 mg/kg/day) for improving both metabolic syndrome and SHR-SR hypertension. Results: Compared to normotensive Wistar rats, long-lasting hypertension in SHR-SR disrupted NVU by changing immunohistological components such as NAGO, collagen IV, astrocytes, and MMP-9. SHR-SR also strongly induced AD-related inflammasome NLRP3 in neuronal cells with age. However, such NVU disruption and inflammasome activation were greatly improved with dose-dependent telmisartan treatments. Discussion: These results suggest that telmisartan comprehensively protected the NVU components by reducing inflammatory reactions relative to AD in hypertensive rats, which could also preclude the risk of AD under hypertension.

AB - Objectives: Hypertension is a crucial risk factor for both stroke and dementia, including Alzheimer’s disease (AD). We inspected the effect of telmisartan on the neurovascular unit (NVU) and related inflammatory responses in spontaneously hypertensive rat stroke resistant (SHR-SR) by observing the components of NVU such as N-acetyl glucosamine oligomer (NAGO), collagen IV, astrocytes, and matrix metalloproteinase-9 (MMP-9), as well as inflammasome NOD-like receptors family protein 3 (NLRP3). Methods: In the present study, we examined the effect of a highly selective angiotensin type 1 (AT-1) antagonist of angiotensin 2 receptor with high lipid solubility, telmisartan, on NVU and related inflammatory responses in SHR-SR with a low dose (0.3 mg/kg/day) only for improving metabolic syndrome, and a high dose (3 mg/kg/day) for improving both metabolic syndrome and SHR-SR hypertension. Results: Compared to normotensive Wistar rats, long-lasting hypertension in SHR-SR disrupted NVU by changing immunohistological components such as NAGO, collagen IV, astrocytes, and MMP-9. SHR-SR also strongly induced AD-related inflammasome NLRP3 in neuronal cells with age. However, such NVU disruption and inflammasome activation were greatly improved with dose-dependent telmisartan treatments. Discussion: These results suggest that telmisartan comprehensively protected the NVU components by reducing inflammatory reactions relative to AD in hypertensive rats, which could also preclude the risk of AD under hypertension.

KW - AD

KW - Hypertension

KW - Inflammasome

KW - Neurovascular unit

KW - SHR-SR

KW - Telmisartan

UR - http://www.scopus.com/inward/record.url?scp=84929718564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929718564&partnerID=8YFLogxK

U2 - 10.1179/1743132815Y.0000000002

DO - 10.1179/1743132815Y.0000000002

M3 - Article

VL - 37

SP - 491

EP - 501

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 6

ER -